| Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome (NCT04117802) | Laval University | 2019-09-03 |
| Macrophage-mediated Inflammation in White Adipose Tissue and Non-alcoholic Fatty Liver Disease. (NCT04059068) | Imperial College London | 2019-09-01 |
| Alternate Day Fasting, Exercise, and NAFLD (NCT04004403) | University of Illinois at Chicago | 2019-09-01 |
| The Effect of Probiotics on the Clinical Outcomes and Gut Microenvironment in Patients With Fatty Liver (NCT04074889) | Universiti Kebangsaan Malaysia Medical Centre | 2019-08-30 |
| Study to Evaluate the Efficacy and Safety of CC-90001 in Participants With Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis (NCT04048876) | Celgene | 2019-08-14 |
| Super HEROES: Searching How the Extract Rebaudioside Occludes Excess Steatosis (NCT03985020) | Children's Hospital Los Angeles | 2019-07-26 |
| Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES) (NCT03884075) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2019-07-24 |
| The Efficacy and Safety of Ornithine Aspartic Acid Granules in NAFLD Against Silymarin Capsules (NCT05042245) | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 2019-07-23 |
| Integrated Approaches for Identifying Molecular Targets in Liver Disease (NCT03915002) | University of Pittsburgh | 2019-06-13 |
| NAFLD Among Patients With Chronic Kidney Disease and the Effect of Kidney Transplantation (NCT03866421) | Rigshospitalet, Denmark | 2019-05-29 |
| Effect of Patient Demographics, Comorbidities, and Medications on Severity of NASH Fibrosis (NCT05357352) | Methodist Health System | 2019-05-24 |
| Investigation on the Role of Gut-liver Axis for Non-alcoholic Steatohepatitis Through Bariatric Surgery (NCT04501042) | National Taiwan University Hospital | 2019-05-16 |
| NAFLD Among Patients With Type 2 Diabetes and CKD (NCT03826381) | Rigshospitalet, Denmark | 2019-05-06 |
| NASH and Coronary Disease (NCT03819283) | Assistance Publique - Hôpitaux de Paris | 2019-04-19 |
| Exercise Study in Subjects With NAFLD (NCT03995056) | University of Eastern Finland | 2019-04-19 |
| Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver Diseases (NCT03910361) | Dong-A ST Co., Ltd. | 2019-04-12 |
| Biological Adaptations of Strength Training. (NCT04098484) | Democritus University of Thrace | 2019-04-02 |
| Change of Adipose Tissues and Triglyceride After Bariatric Surgery or Life-style Intervention (NCT03875625) | Chinese University of Hong Kong | 2019-04-01 |
| Effect of Modified Time-restricted Feeding in Preventing Progression of Non-Alcoholic Fatty Liver Disease (NAFLD). (NCT03848390) | The University of Texas Health Science Center, Houston | 2019-04-01 |
| Measuring Fatty Liver With Ultrasound and MRS in Children With Overweight or Obesity (NCT03787108) | Maastricht University Medical Center | 2019-03-31 |
| Structured Mobile Technology Based Lifestyle Program vs Usual Care for Patients With Non-alcoholic Fatty Liver Disease (NCT03839082) | University of Michigan | 2019-03-20 |
| Role of Obeticholic Acid in the Patients of NAFLD With Raised ALT (NCT03836937) | Sir Salimullah Medical College Mitford Hospital | 2019-03-05 |
| Investigating Pathological Mechanisms in Non-alcoholic Fatty Liver Disease (NCT04141592) | Queen Mary University of London | 2019-03-05 |
| The Effect of Curcumin on Liver Fat Content in Obese Subjects (NCT03864783) | Steno Diabetes Center Copenhagen | 2019-03-05 |
| Evaluating the Efficacy of CPAP Therapy for the Treatment of Fatty Liver (NCT01849081) | Massachusetts General Hospital | 2019-03-01 |
| Efficacy of Silymarin in Patients With Non-alcoholic Fatty Liver Disease - The SILIVER Trial (NCT03749070) | Camila Ribeiro de Avelar | 2019-02-15 |
| Hepaxa Management of Non-alcoholic Fatty Liver Disease (NCT03801577) | BASF AS | 2019-02-01 |
| Liver Health and Metabolic Function in People With Obesity (NCT03701828) | Washington University School of Medicine | 2019-02-01 |
| Hepatic Histology and Metabolism Following Total Pancreatectomy and Pancreaticoduodenectomy (NCT03864744) | Steno Diabetes Center Copenhagen | 2019-01-30 |
| Cold-induced Brown Fat Activation and Hepatic Steatosis (NCT03811236) | Medical University of Vienna | 2019-01-21 |
| Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk (NCT03375788) | Massachusetts General Hospital | 2019-01-17 |
| Nicotinamide in Non-Alcoholic Fatty Liver Disease Patients (NCT03850886) | Ain Shams University | 2019-01-15 |
| Accuracy of Imaging Techniques in Diagnosing Steatohepatitis and Fibrosis in NAFLD Patients (NCT04785937) | Azienda USL Reggio Emilia - IRCCS | 2019-01-01 |
| 12-Month Once-a-week HIIT Improves Body Adiposity and Liver Fat (NCT03912272) | The University of Hong Kong | 2019-01-01 |
| Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease (NCT03590626) | Medanta, The Medicity, India | 2019-01-01 |
| Metabolic Phenotyping and Follow-Up of Patients With and Without Diabetes After New Onset of STEMI (NCT05046483) | German Diabetes Center | 2018-12-30 |
| Antidiabetic Drugs for Steatotic Liver Disease (NCT03646292) | Yonsei University | 2018-12-06 |
| Early Detection of Advanced Fatty Liver Disease (NCT03608748) | HaEmek Medical Center, Israel | 2018-11-01 |
| Functional Roll for Non-alcoholic Fatty Liver Disease (NCT04520724) | Pomeranian Medical University Szczecin | 2018-11-01 |
| Diabetes, Exercise and Liver Fat (DELIVER) (NCT04004273) | James King | 2018-10-30 |
| Berberine and Non-Alcoholic Fatty Liver Disease (NAFLD) (NCT04049396) | Lida Nejati | 2018-10-01 |
| Evaluation of the Pharmacokinetics of Tropifexor in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Healthy Control Subjects (NCT03681457) | Novartis Pharmaceuticals | 2018-09-24 |
| Quality of Life in Non-alcoholic Fatty Liver Disease (QOLNAFLD) (NCT03613480) | University Hospital of Patras | 2018-09-01 |
| Hydrogen-rich Water for Non-alchoholic Fatty Liver Disease (NCT03625362) | University of Novi Sad, Faculty of Sport and Physical Education | 2018-09-01 |
| Dynamic Changes and Risk Factors of Fibrosis and Steatosis Progression in Nonalcoholic Fatty Liver Disease (NCT03635541) | Beijing Friendship Hospital | 2018-08-23 |
| Prognostic Significance of Fatty Liver Disease in Bariatric Patients (NCT03535142) | Esbjerg Hospital - University Hospital of Southern Denmark | 2018-08-15 |
| Efficacy of Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets on the Patients With Newly Diagnosed Type 2 Diabetes Mellitus Combined With Non-alcoholic Fatty Liver Disease (NCT03796975) | Xijing Hospital | 2018-06-28 |
| Novel Antidiabetic Medications and Their Effect on Liver Steatosis (NAMELS-18) (NCT05946148) | National and Kapodistrian University of Athens | 2018-06-01 |
| Effects of Probiotic on Inflammation and Microbiota in Patients With NASH (NCT03511365) | Northwell Health | 2018-05-15 |
| Non Invasive Electrical Impedance Technology (EIT) for Diagnosing Liver Diseases Severity (NCT03492879) | Prof. Ziv Ben-Ari MD | 2018-05-15 |
| Technical Validation of MR Biomarkers of Obesity-Associated NAFLD (NCT03674528) | University of Wisconsin, Madison | 2018-05-04 |
| Plant Sterols and Plant Stanols and Liver Inflammation (NCT03627819) | Maastricht University Medical Center | 2018-05-04 |
| Hepatic Metabolic Changes in Response to Glucagon Infusion (NCT03526445) | Steno Diabetes Center Copenhagen | 2018-05-01 |
| Assessment of Renal Changes in Patients With Non Alcoholic Fatty Liver Disease (NCT03487068) | Assiut University | 2018-04-30 |
| Multicenter, Randomized, Controlled and Double-blind Study of Efficacy and Safety of Endoscopic Gastric Tubulization in Patients With Non-alcoholic Steatohepatitis (NASH-APOLLO). (NCT03426111) | Puerta de Hierro University Hospital | 2018-04-18 |
| Effects of Carnitine Supplementation on Liver and Muscle (NCT03439917) | University of Nottingham | 2018-04-02 |
| Gemcabene for the Treatment of Pediatric NAFLD (NCT03436420) | Emory University | 2018-03-29 |
| The Influence of SARS-CoV-2 Lifestyle Changes on Non-alcoholic Fatty Liver Disease Evolution (NCT05416970) | University of Campania Luigi Vanvitelli | 2018-01-01 |
| Intermittent Fasting in Nonalcoholic Fatty Liver Disease (NCT04355910) | Shaoguan University | 2018-01-01 |
| Non-invasive Diagnostic Model of Liver Fibrosis Associated With NAFLD and Prediction of Prognosis (NCT03842748) | Beijing Municipal Administration of Hospitals | 2018-01-01 |
| A Study of Pemafibrate in Patients With Nonalcoholic Fatty Liver Disease (NAFLD) (NCT03350165) | Kowa Company, Ltd. | 2017-12-27 |
| ObeSity Related Colorectal Adenoma Risk (NCT03663062) | South Tyneside and Sunderland NHS Foundation Trust | 2017-12-27 |
| Obstructive Sleep Apnea and Non-alcoholic Fatty Liver Disease (NCT03373643) | University Hospital, Angers | 2017-12-14 |
| High-fat Overfeeding, Hepatokines and Appetite Regulation (NCT03369145) | Loughborough University | 2017-12-11 |
| Combining MRI Steatosis Assessment and Transient Elastography to Improve Liver Fibrosis Diagnosis in Non Alcoholic Fatty Liver Disease (NCT03245606) | Rennes University Hospital | 2017-12-07 |
| Effects of Dietary Fructose on Gut Microbiota and Fecal Metabolites in Obese Men and Postmenopausal Women: A Pilot Study (NCT03339245) | Rockefeller University | 2017-12-05 |
| Probiotics in NASH Patients - PROBILIVER TRIAL (NCT03467282) | Hospital de Clinicas de Porto Alegre | 2017-11-29 |
| A Study on How Semaglutide Works on Early Stages of Scar Tissue in the Liver Assessed by Pictures of the Liver (NCT03357380) | Novo Nordisk A/S | 2017-11-28 |
| European Paediatric Non-Alcoholic Fatty Liver Disease Registry (EU-PNAFLD) (NCT04190849) | Cambridge University Hospitals NHS Foundation Trust | 2017-11-14 |
| Intestinal Microbiota Transplantation for Nonalcoholic Fatty Liver Disease (NCT03648086) | Zhongshan Hospital Xiamen University | 2017-11-14 |
| Cigarette Smoking in Non-alcoholic Steatohepatitis (NCT04688307) | Tehran University of Medical Sciences | 2017-11-01 |
| Prevention and Reversion of NAFLD in Obese Patients With Metabolic Syndrome by Mediterranean Diet and Physical Activity (NCT04442620) | University of the Balearic Islands | 2017-10-26 |
| 6-week Safety and PD Study in Adults With NAFLD (NCT03256526) | Pfizer | 2017-09-27 |
| Fatty Liver Disease in Nordic Countries (NCT04340817) | Copenhagen University Hospital, Hvidovre | 2017-09-01 |
| Diaphragmatic Breathing Exercise Improves Non-alcoholic Fatty Liver Disease (NCT02863393) | Taipei Medical University WanFang Hospital | 2017-08-29 |
| Hepatic Urea Nitrogen Handling in Patients With NASH (NCT03260036) | University of Aarhus | 2017-08-21 |
| Non Alcoholic Fatty Liver Disease: Nutritional Epidemiology and Lifestyle Medicine (NCT03300661) | Università degli Studi di Brescia | 2017-06-13 |
| Effects of Dietary Intervention and Surgery on NAFLD (Non-Alcoholic Fatty Liver Disease) (NCT03186859) | University of Oxford | 2017-06-09 |
| Different Doses of BI 1467335 Compared to Placebo in Patients With Clinical Evidence of NASH (NCT03166735) | Boehringer Ingelheim | 2017-06-06 |
| Pradaxa Tablet Proton Pump Inhibitor (PPI) Bioavailability (BA) Study in Japan (NCT03143166) | Boehringer Ingelheim | 2017-05-22 |
| Nonalcoholic Steatohepatitis in Chinese Children (NCT03190538) | Humanity and Health Research Centre | 2017-05-01 |
| Interval Training Versus Electro Acupuncture on Liver Functions in Patients With Non-alcoholic Fatty Liver Disease (NCT03936803) | Cairo University | 2017-05-01 |
| Saroglitazar Magnesium in Patients With Nonalcoholic Fatty Liver Disease and/or Nonalcoholic Steatohepatitis (NCT03061721) | Zydus Therapeutics Inc. | 2017-04-06 |
| Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis (NCT03059446) | Tobira Therapeutics, Inc. | 2017-02-14 |
| Effect of PNPLA3, TM6SF2 and MBOAT7 Genetic Variants on Non-alcoholic Fatty Liver Disease Therapeutic Outcome. (NCT04640324) | University of Campania Luigi Vanvitelli | 2017-01-16 |
| Safety And Efficacy Study Of Orally Administered Epeleuton In Patients With NAFLD (NCT02941549) | Afimmune | 2016-12-20 |
| the Role of plin5 in the Development of Nonalcoholic Fatty Liver Disease. (NCT04104282) | Xijing Hospital | 2016-12-01 |
| Ultrasound Quantification of Liver Fat (NCT04523584) | Children's Hospital Medical Center, Cincinnati | 2016-11-08 |
| A Reduced-carbohydrate Diet High in Monounsaturated Fats in Type 2 Diabetes (NCT03068078) | Odense University Hospital | 2016-11-01 |
| Fucoidan Improves the Metabolic Profiles of Patients With Non-alcoholic Fatty Liver Disease (NAFLD) (NCT02875392) | Taipei Medical University WanFang Hospital | 2016-11-01 |
| Metabolic Flexibility, Gut Microbiota, Healthy Diet and Exercise in NAFLD on Genetics Base (NCT02951546) | University of Roma La Sapienza | 2016-10-01 |
| Single Dose of PF-06835919 Escalation Study in Healthy Adult Subjects (NCT02974374) | Pfizer | 2016-10-01 |
| A Study to Evaluate the Safety, Tolerability & Efficacy of MSDC-0602K in Patients With NASH (NCT02784444) | Cirius Therapeutics, Inc. | 2016-09-14 |
| Chia Supplementation and Non Alcoholic Fatty Liver Disease (NCT03942822) | Instituto Nacional de Cardiologia Ignacio Chavez | 2016-09-01 |
| Screening Diabetes Patients for NAFLD With Controlled Attenuation Parameter and Liver Stiffness Measurements (NCT03060694) | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 2016-09-01 |
| A Prospective Study of HBV Immunity and HBV Vaccination in Patients With NAFLD in Canada (NCT02985450) | University of Calgary | 2016-08-01 |
| Obstructive Sleep Apnoea and CPAP Treatment Response in Patients With Non-alcoholic Fatty Liver Disease (NCT02728765) | Chinese University of Hong Kong | 2016-07-05 |
| Fatty Liver in Obesity: Long-lifestyle Follow-up (FLiO) (NCT03183193) | Clinica Universidad de Navarra, Universidad de Navarra | 2016-06-01 |
| Runihol in Nonalcoholic Fatty Liver Disease and Metabolic Syndrome (NCT02930161) | POLYSAN Scientific & Technological Pharmaceutical Company | 2016-05-30 |
| A Carbohydrate-restricted Diet to Reverse Fatty Liver in Adolescents With Obesity (NCT02787668) | University of Alabama at Birmingham | 2016-05-01 |